Online Database of Chemicals from Around the World

Ketamine hydrochloride
[CAS# 1867-66-9]

List of Suppliers
Hefei TNJ Chemical Industry Co., Ltd. China Inquire
www.tnjchem.com
+86 (551) 6541-8684
+86 (551) 6541-8697
sales@tnjchem.com
Chemical manufacturer since 2001
chemBlink Standard supplier since 2010
Medilink Pharmachem India Inquire
www.medilinkpharma.com
+91 (79) 3007-0133
+91 (79) 4007-4175
exports@medilinkpharma.com
Chemical distributor since 1996
chemBlink Standard supplier since 2014
Tecoland Corporation USA Inquire
www.tecoland.com
+1 (732) 603-9577
+1 (732) 906-1522
info@tecoland.com
Chemical distributor since 2001
chemBlink Standard supplier since 2019
Alsachim SAS France Inquire
www.alsachim.com
+33 (0) 390 402 200
+33 (0) 390 402 199
contact@alsachim.com
Chemical manufacturer

Identification
ClassificationAnalytical chemistry >> Standard >> Pharmacopoeia standards and magazine standards
NameKetamine hydrochloride
Synonyms(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride
Molecular StructureCAS # 1867-66-9, Ketamine hydrochloride
Molecular FormulaC13H16ClNO.HCl
Molecular Weight274.19
CAS Registry Number1867-66-9
EC Number217-484-6
SMILESCNC1(CCCCC1=O)C2=CC=CC=C2Cl.Cl
Properties
SolubilitySoluble 100 mM (water)
Safety Data
Hazard Symbolssymbol symbol   GHS07;GHS08 Warning  Details
Risk StatementsH302-H315-H319-H335-H361-H373  Details
Safety StatementsP203-P260-P261-P264-P264+P265-P270-P271-P280-P301+P317-P302+P352-P304+P340-P305+P351+P338-P318-P319-P321-P330-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501  Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
Eye irritationEye Irrit.2H319
Skin irritationSkin Irrit.2H315
Specific target organ toxicity - single exposureSTOT SE3H335
Reproductive toxicityRepr.2H361
Specific target organ toxicity - repeated exposureSTOT RE2H373
Acute toxicityAcute Tox.4H332
Acute toxicityAcute Tox.4H301
CarcinogenicityCarc.2H351
Acute toxicityAcute Tox.3H301
Specific target organ toxicity - single exposureSTOT SE3H336
SDSAvailable
up Discovery and Applications
Ketamine hydrochloride, commonly known as ketamine, was discovered in the early 1960s by Dr. Calvin Stevens, a researcher at Parke-Davis Laboratories. Initially developed as a derivative of phencyclidine (PCP), ketamine was intended for use as a general anesthetic. Its unique properties, including rapid onset, short duration of action, and minimal suppression of cardiovascular and respiratory functions, distinguished it from existing anesthetics. Ketamine's discovery marked a significant advancement in anesthesia, offering an alternative to traditional agents like thiopental and halothane.

One of the primary applications of ketamine hydrochloride is in anesthesia. It is used for induction and maintenance of anesthesia in various medical procedures, including surgery, diagnostic interventions, and sedation in critical care settings. Ketamine's unique pharmacological profile, characterized by its dissociative anesthesia, analgesic properties, and preservation of cardiovascular stability, makes it particularly suitable for use in patients with compromised hemodynamics or airway reflexes.

Ketamine is also employed in pain management, both as a standalone analgesic and as an adjunct to other pain medications. Its N-methyl-D-aspartate (NMDA) receptor antagonism and modulation of central sensitization mechanisms contribute to its efficacy in managing acute and chronic pain conditions, including neuropathic pain, complex regional pain syndrome (CRPS), and postoperative pain.

In recent years, ketamine has gained attention for its antidepressant effects, particularly in individuals with treatment-resistant depression (TRD). Ketamine's rapid onset of action and ability to induce profound and sustained antidepressant effects in TRD patients have led to its use as an off-label treatment in psychiatry.

Ketamine hydrochloride is widely employed in veterinary medicine for anesthesia and analgesia in animals. Its efficacy, safety profile, and rapid recovery make it a preferred choice for veterinary procedures, including surgeries, dental extractions, and diagnostic imaging.

Beyond its established medical applications, ketamine continues to be studied for its potential therapeutic effects in various conditions, including post-traumatic stress disorder (PTSD), substance use disorders, and neurodegenerative diseases. Research efforts focus on elucidating the underlying mechanisms of ketamine's pharmacological actions and optimizing its clinical use.

References

none
Market Analysis Reports
List of Reports Available for Ketamine hydrochloride
Related Products
Kerosine (Petro...  Kerriamycin A  Kerriamycin B  Kerriamycin C  alpha-Kessyl Al...  1-Kestoheptaose  1,1,1,1-Kestohe...  (+)-Ketamine  Ketamine  Ketamine-d4 Hyd...  (S)-(+)-Ketamin...  Ketanserin  Ketanserinol  Ketanserin tart...  Ketazocine Hydr...  Ketazolam  Ketene  Kethoxal  Ketimipramine  Ketipramine Fum...